Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medipharm Labs Corp
T.LABS
Alternate Symbol(s):
MEDIF
Healthcare
Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,...
packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:LABS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
...
Next
(571)
•••
mdjbrown
X
View Profile
View Bullboard History
Post by
mdjbrown
on Feb 13, 2024 11:31am
Looks like AVCN has been busy the past couple months
Wonder what this comment is all about, and why we havent heard anything from Medipharm? "Additionally, the two companies have entered into a separate right of first refusal agreement related to
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Feb 13, 2024 11:15am
DEA IS DONE DEAL!!!
hint: FDA and NIH engaged the DEA to issue export permits to LABS for clinical trials in the U.S. That was months ago. Eyes in the sky.....major news pending....so sit tight and
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Comment by
subaru1i
on Feb 13, 2024 11:07am
RE:RE:RE:RE:RE:Interesting news from Avicanna
.....is there enough time before DEA? I could see it after DEA rescheduling.
(571)
•••
mdjbrown
X
View Profile
View Bullboard History
Comment by
mdjbrown
on Feb 13, 2024 10:55am
RE:RE:RE:RE:Interesting news from Avicanna
s1i, wouldnt Avicanna make an interesting take-over target for Medipharm considering their current relationship
(264)
•••
alleyesonme
X
View Profile
View Bullboard History
Comment by
alleyesonme
on Feb 13, 2024 10:53am
RE:RE:RE:RE:Interesting news from Avicanna
Very interesting, 10% Cannabidiol (CBD) as opposed to 90%epidiolex, this drug would fall under 505b2 through FDA application, Avicanna /Labs, close business relationship aforementioned in the expanded
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Comment by
subaru1i
on Feb 13, 2024 10:43am
RE:RE:RE:Interesting news from Avicanna
hmmm....perhaps a generic Epidiolex for Canada with LABS?
(571)
•••
mdjbrown
X
View Profile
View Bullboard History
Comment by
mdjbrown
on Feb 13, 2024 10:32am
RE:RE:Interesting news from Avicanna
s1i, Avicanna may have already solved that conundrum https://www.avicanna.com/avicanna-and-ease-labs-pharma-granted-commercialization-approval-for-pharmaceutical-preparation-in-brazil/ I
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Feb 13, 2024 10:20am
ps: DEA has news pending....sit tight
everyone!!! (eyes in the sky)
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Comment by
subaru1i
on Feb 13, 2024 10:19am
RE:Interesting news from Avicanna
Trunerox (Epidiolex generic) for Columbia, NOT Brazil but reference 'expanded strategic manufacturing agreement between LABS and Avicanna and ANVISA approvals for LABS.....could be Avicanna's
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Comment by
subaru1i
on Feb 13, 2024 10:15am
RE:Question
'advanced derivative cannabinoids'........proprietary VIVO acquistion....more than enough capacity acid form of cannabinoids.....increases production capacity equivalent to 100 times more
...more
(571)
•••
mdjbrown
X
View Profile
View Bullboard History
Post by
mdjbrown
on Feb 13, 2024 10:08am
Interesting news from Avicanna
Trunerox sounds a lot like a generic Epidiolex “The approval of our first pharmaceutical product is an exceptionally significant milestone and a major step towards our long-term vision as a
...more
(615)
•••
okgonow
X
View Profile
View Bullboard History
Comment by
okgonow
on Feb 13, 2024 10:01am
RE:RE:RE:RE:Question
thanks star
(80)
•••
Starkicker
X
View Profile
View Bullboard History
Comment by
Starkicker
on Feb 13, 2024 9:58am
RE:RE:RE:Question
Hey Okgonow, AllEyes is right. There is no shortage of flower to purchase. I think something like 3.7 million pounds of unsold and unpackaged cannabis was thrown out by LPs last year because there was
...more
(615)
•••
okgonow
X
View Profile
View Bullboard History
Comment by
okgonow
on Feb 13, 2024 9:57am
RE:RE:Question
i guess one mans excellent questions, are another mans irritatating questions?! LOL
Prev
...
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >